✨ Fisheries and Health Notices
NEW ZEALAND GAZETTE, No. 121
16 SEPTEMBER 2004
Schedule
| Species | Fishstock Code | Quota Management Area | Quota Management System Fishstock Code | Total Allowable Commercial Catch (greenweight tonnes) |
|---|---|---|---|---|
| Scampi | SCI1 | 1 | SCI1 | 120 |
| SCI2 | 2 | SCI2 | 200 | |
| SCI3 | 3 | SCI3 | 340 | |
| SCI4A | 4A | SCI4A | 120 | |
| SCI5 | 5 | SCI5 | 40 | |
| SCI6A | 6A | SCI6A | 306 | |
| SCI6B | 6B | SCI6B | 50 | |
| SCI7 | 7 | SCI7 | 75 | |
| SCI8 | 8 | SCI8 | 5 | |
| SCI9 | 9 | SCI9 | 35 | |
| SCI10 | 10 | SCI10 | 0 |
Dated at Wellington this 14th day of September 2004.
DAVID BENSON-POPE, Minister of Fisheries.
Explanatory Note
This note is not part of the notice, but is intended to indicate its general effect.
This notice, which comes into force on 30 September 2004, sets the total allowable commercial catch for each quota management stock listed, on and from the first day of the next fishing year.
Health
Medicines Act 1981
Consent to the Distribution of a Changed Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health, under the provisions of section 24 (5) of the Act, and is set out in the Schedule hereto:
Schedule
Product:
Tripacel
Active Ingredients:
- Diphtheria toxoid, adsorbed 30IU
- Pertactin 3µg/dose
- Pertussis filamentous haemagglutinin 5µg/dose
- Pertussis fimbriae 2+3 5µg/dose
- Pertussis toxoid, adsorbed 10µg/dose
- Tetanus toxoid, adsorbed 40IU
Dosage Form:
Suspension for injection
New Zealand Sponsor:
Aventis Pharma Limited
Manufacturer:
Aventis Pasteur Limited, Toronto, Ontario, Canada
Dated this 9th day of September 2004.
GRAEME GILLESPIE, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product:
Diamide
Active Ingredient:
Loperamide hydrochloride 2mg
Dosage Form:
Capsule
New Zealand Sponsor:
Pacific Pharmaceuticals Limited
Manufacturer:
McDermott Laboratories, t/a Gerard Laboratories, Dublin, Ireland
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2004, No 121
Gazette.govt.nz —
NZ Gazette 2004, No 121
✨ LLM interpretation of page content
🌾
Fisheries (Scampi Total Allowable Commercial Catch) Notice 2004
(continued from previous page)
🌾 Primary Industries & Resources14 September 2004
Fisheries, Scampi, Total Allowable Commercial Catch, Quota Management, Fisheries Act 1996
- DAVID BENSON-POPE, Minister of Fisheries
🏥 Consent to the Distribution of a Changed Medicine (Tripacel)
🏥 Health & Social Welfare9 September 2004
Medicines, Distribution, Tripacel, Diphtheria toxoid, Pertussis, Tetanus toxoid, Aventis Pharma Limited, Aventis Pasteur Limited
- GRAEME GILLESPIE, Acting Deputy Director-General, Public Health
🏥 Consent to the Distribution of a New Medicine (Diamide)
🏥 Health & Social Welfare9 September 2004
Medicines, Distribution, Diamide, Loperamide hydrochloride, Pacific Pharmaceuticals Limited, McDermott Laboratories
- GRAEME GILLESPIE, Acting Deputy Director-General, Public Health